Abstract
Intact CD3-specific antibody transiently depletes large numbers of T cells and subsequently induces long-term immune tolerance. The underlying mechanisms for the systemic tolerance, however, remain unclear. We show here that treatment of normal mice with intact antibody to CD3 increases systemic transforming growth factor-β (TGF-β) produced by phagocytes exposed to apoptotic T cells. Among the phagocytes, macrophages and immature dendritic cells (iDCs) secrete TGF-β upon ingestion of apoptotic T cells, which induces CD4+Foxp3+ regulatory T cells in culture and contributes to immune tolerance mediated by CD3-specific antibody in vivo. In accordance with these results, depletion of macrophages and iDCs not only abrogates CD3-specific antibody–mediated prevention of myelin oligodendrocyte glycoprotein–induced acute experimental autoimmune encephalomyelitis (EAE), but also reverses the therapeutic effects of antibody to CD3 on established disease in a model of relapsing-remitting EAE. Thus, CD3-specific antibody–induced immune tolerance is associated with TGF-β production in phagocytes involved in clearing apoptotic T cells, which suggests that apoptosis is linked to active suppression in immune tolerance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bach, J.F. & Chatenoud, L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131–161 (2001).
Chatenoud, L. CD3-specific antibody–induced active tolerance: from bench to bedside. Nat. Rev. Immunol. 3, 123–132 (2003).
Masteller, E.L. & Bluestone, J.A. Immunotherapy of insulin-dependent diabetes mellitus. Curr. Opin. Immunol. 14, 652–659 (2002).
Nicolls, M.R. et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3–like monoclonal antibody. Transplantation 55, 459–468 (1993).
Smith, J.A. & Bluestone, J.A. T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. Curr. Opin. Immunol. 9, 648–654 (1997).
Smith, J.A., Tso, J.Y., Clark, M.R., Cole, M.S. & Bluestone, J.A. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J. Exp. Med. 185, 1413–1422 (1997).
Belghith, M. et al. TGF-β–dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9, 1202–1208 (2003).
Ochi, H. et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells. Nat. Med. 12, 627–635 (2006).
Chatenoud, L., Primo, J. & Bach, J.F. CD3 antibody–induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947–2954 (1997).
Hirsch, R., Gress, R.E., Pluznik, D.H., Eckhaus, M. & Bluestone, J.A. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. In vivo activation of T cells. J. Immunol. 142, 737–743 (1989).
Chen, W., Frank, M.E., Jin, W. & Wahl, S.M. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14, 715–725 (2001).
Fadok, V.A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2 and PAF. J. Clin. Invest. 101, 890–898 (1998).
Ferguson, T.A. & Green, D.R. T cells are just dying to accept grafts. Nat. Med. 5, 1231–1232 (1999).
Shortman, K. & Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151–161 (2002).
Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003).
Hirsch, R., Gress, R.E. & Bluestone, J.A. Anti-CD3 antibody for autoimmune disease, a cautionary note. Lancet 1, 1390 (1989).
Ferran, C. et al. Anti–tumor necrosis factor modulates anti-CD3–triggered T cell cytokine gene expression in vivo. J. Clin. Invest. 93, 2189–2196 (1994).
Ferran, C. et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20, 509–515 (1990).
Kleinclauss, F. et al. Intravenous apoptotic spleen cell infusion induces a TGF-β–dependent regulatory T-cell expansion. Cell Death Differ. 13, 41–52 (2006).
Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
Chatenoud, L. & Bluestone, J.A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7, 622–632 (2007).
Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J. & Owen, J.J. Antibodies to CD3–T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181–184 (1989).
Albert, M.L. et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188, 1359–1368 (1998).
Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163–2173 (1998).
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
Gandhi, R., Anderson, D.E. & Weiner, H.L. Cutting edge: immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-β–dependent manner. J. Immunol. 178, 4017–4021 (2007).
Luo, X. et al. Dendritic cells with TGF-β1 differentiate naive CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821–2826 (2007).
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
Chen, W. et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
Wan, Y.Y. & Flavell, R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126–5131 (2005).
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237–1240 (1994).
Zamvil, S.S. et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324, 258–260 (1986).
Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006).
Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17–producing T cells. Immunity 24, 179–189 (2006).
Kohm, A.P. et al. Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis. J. Immunol. 174, 4525–4534 (2005).
Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423–431 (2007).
Menoret, A. et al. TGF-β protein processing and activity through TCR triggering of primary CD8+ T regulatory cells. J. Immunol. 177, 6091–6097 (2006).
Wahl, S.M. et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788–5792 (1987).
Wakefield, L.M., Smith, D.M., Masui, T., Harris, C.C. & Sporn, M.B. Distribution and modulation of the cellular receptor for transforming growth factor-β. J. Cell Biol. 105, 965–975 (1987).
Liu, Y.J. IPC: Professional type 1 interferon–producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275–306 (2005).
Marie, J.C., Letterio, J.J., Gavin, M. & Rudensky, A.Y. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061–1067 (2005).
Wan, Y.Y. & Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766–770 (2007).
Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277–284 (2007).
Pasare, C. & Medzhitov, R. Toll pathway–dependent blockade of CD4+CD25+ T cell–mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
Liu, Y., Amarnath, S. & Chen, W. Requirement of CD28 signaling in homeostasis/survival of TGF-β converted CD4+CD25+ Tregs from thymic CD4+CD25− single positive T cells. Transplantation 82, 953–964 (2006).
Perruche, S. et al. A single-platform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow transplantation. J. Immunol. Methods 294, 53–66 (2004).
Acknowledgements
This research was supported by the Intramural Research Program of the NIDCR and NIH grant R37AI46643 (J.A.B.).
Author information
Authors and Affiliations
Contributions
S.P. designed and did experiments, analyzed data and contributed to the writing of the manuscript; P.Z. designed and did experiments; Y.L. and P.S. did experiments; J.A.B. provided critical input on the EAE treatment studies and the nonmitogenic CD3-specific IgG3 antibody; W.C. initiated and directed the whole study, designed experiments, analyzed data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
J.A.B. is a consultant for and has an equity stake in Macrogenics Corporation, which is developing a monoclonal antibody to CD3.
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1–7, Supplementary Tables 1 and 2, and Supplementary Methods (PDF 1505 kb)
Rights and permissions
About this article
Cite this article
Perruche, S., Zhang, P., Liu, Y. et al. CD3-specific antibody–induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat Med 14, 528–535 (2008). https://doi.org/10.1038/nm1749
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1749
This article is cited by
-
T cell plasticity in renal autoimmune disease
Cell and Tissue Research (2021)
-
Extracellular Vesicles from Apoptotic Cells Promote TGFβ Production in Macrophages and Suppress Experimental Colitis
Scientific Reports (2019)
-
Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy
Arthritis Research & Therapy (2016)
-
Apoptotic cell-linked immunoregulation: implications for promoting immune tolerance in transplantation
Cell & Bioscience (2015)
-
CD8+NKT-like cells regulate the immune response by killing antigen-bearing DCs
Scientific Reports (2015)